Showing 1 - 10 results of 10 for search 'Dorte Vistisen', query time: 0.04s
Refine Results
-
1
-
2
Association of general health and lifestyle factors with the salivary microbiota – Lessons learned from the ADDITION-PRO cohort by Casper Sahl Poulsen, Nikoline Nygaard, Nikoline Nygaard, Florentin Constancias, Evelina Stankevic, Timo Kern, Daniel R. Witte, Daniel R. Witte, Dorte Vistisen, Dorte Vistisen, Niels Grarup, Oluf Borbye Pedersen, Oluf Borbye Pedersen, Daniel Belstrøm, Torben Hansen
Published 2022-11-01
Article -
3
Childhood body mass index trajectories and associations with adult-onset chronic kidney disease in Denmark: A population-based cohort study by Julie Aarestrup, Kim Blond, Dorte Vistisen, Marit E. Jørgensen, Marie Frimodt-Møller, Britt W. Jensen, Jennifer L. Baker
Published 2022-09-01
Article -
4
Study protocol for optimising glycaemic control in type 1 diabetes treated with multiple daily insulin injections: intermittently scanned continuous glucose monitoring, carbohydrat... by Anna Lilja Secher, Ulrik Pedersen-Bjergaard, Ole Lander Svendsen, Birthe Gade-Rasmussen, Thomas P Almdal, Liv Dørflinger, Dorte Vistisen, Kirsten Nørgaard
Published 2020-04-01
Article -
5
-
6
The association between sleep duration and detailed measures of obesity: A cross sectional analysis in the ADDITION‐PRO study by Mie M. Andersen, Tinne Laurberg, Anne‐Louise Bjerregaard, Annelli Sandbæk, Søren Brage, Dorte Vistisen, Jonas S. Quist, Jens M. Bruun, Daniel R. Witte
Published 2023-06-01
Article -
7
BALDR: A Web-based platform for informed comparison and prioritization of biomarker candidates for type 2 diabetes mellitus. by Agnete T Lundgaard, Frédéric Burdet, Troels Siggaard, David Westergaard, Danai Vagiaki, Lisa Cantwell, Timo Röder, Dorte Vistisen, Thomas Sparsø, Giuseppe N Giordano, Mark Ibberson, Karina Banasik, Søren Brunak
Published 2023-08-01
Article -
8
Empagliflozin Use Is Associated With Lower Risk of All-Cause Mortality, Hospitalization for Heart Failure, and End-Stage Renal Disease Compared to DPP-4i in Nordic Type 2 Diabetes... by Gisle Langslet, Thomas Nyström, Dorte Vistisen, Bendix Carstensen, Emilie Toresson Grip, Paula Casajust, Giorgi Tskhvarashvili, Fabian Hoti, Riho Klement, Kristina Karlsdotter, Mikko Tuovinen, Anne Pernille Ofstad, Maria Lajer, Christina Shay, Lisette Koeneman, Soulmaz Fazeli Farsani, Leo Niskanen, Sigrun Halvorsen
Published 2024-01-01
Article -
9
Protocol for a single-centre, parallel-group, randomised, controlled, superiority trial on the effects of time-restricted eating on body weight, behaviour and metabolism in individ... by Marit E Jørgensen, Graham Finlayson, Dorte Vistisen, Jonas S Quist, Marie M Jensen, Kim K B Clemmensen, Hanne Pedersen, Natasja Bjerre, Joachim Størling, Martin B Blond, Nicolai J Wewer Albrechtsen, Jens J Holst, Signe S Torekov, Satchidananda Panda, Christina Brock, Kristine Færch
Published 2020-08-01
Article -
10
Empagliflozin is associated with lower cardiovascular risk compared with dipeptidyl peptidase-4 inhibitors in adults with and without cardiovascular disease: EMPagliflozin compaRat... by Dorte Vistisen, Bendix Carstensen, Patorno Elisabetta, Stefanie Lanzinger, Elise Chia-Hui Tan, Daisuke Yabe, Dae Jung Kim, Wayne H.-H. Sheu, Cheli Melzer-Cohen, Reinhard W. Holl, Júlio Núñez, Kyoung Hwa Ha, Sigrun Halvorsen, Gisle Langslet, Avraham Karasik, Thomas Nyström, Leo Niskanen, Sonia Guleria, Riho Klement, Marc Carrasco, Johannes Foersch, Christina Shay, Lisette Koeneman, Fabian Hoti, Soulmaz Fazeli Farsani, Kamlesh Khunti, Francesco Zaccardi, Anuradhaa Subramanian, Krishnarajah Nirantharakumar, EMPRISE EU, East Asia Study Group
Published 2023-08-01
Article